Fluorescence:Article Title: Histological interpretation of spitzoid tumours: an extensive machine learning-based concordance analysis for improving decision making.
Article Snippet: .. CDKN2A status was assessed by fluorescence in-situ hybridisation (FISH) using a 9p21 probe (Vysis LSI 9p21; Abbot Molecular Inc., Des Plaines, IL, USA), labelled with spectrum-red 2824 fluorophore, and a Chr9 centromeric probe (Vysis LSI CEP; Abbott) labelled with spectrum-green fluorophore and with Salsa methylation-specific multiplex ligationdependent probe amplification (MLPA) probemix ME024-B2 9p21 CDKN2A/2B region (MRC-Holland, Amsterdam, the Netherlands).15 We further obtained information on BRAF and NRAS mutation status by immunohistochemistry (anti-BRAF V600E, clone: VE1; Ventana ; anti-RAS Q61R, clone: SP174 Abcam , respectively) and/or next-generation sequencing (NGS) for atypical and malignant lesions. ..
Hybridization:Article Title: Histological interpretation of spitzoid tumours: an extensive machine learning-based concordance analysis for improving decision making.
Article Snippet: .. CDKN2A status was assessed by fluorescence in-situ hybridisation (FISH) using a 9p21 probe (Vysis LSI 9p21; Abbot Molecular Inc., Des Plaines, IL, USA), labelled with spectrum-red 2824 fluorophore, and a Chr9 centromeric probe (Vysis LSI CEP; Abbott) labelled with spectrum-green fluorophore and with Salsa methylation-specific multiplex ligationdependent probe amplification (MLPA) probemix ME024-B2 9p21 CDKN2A/2B region (MRC-Holland, Amsterdam, the Netherlands).15 We further obtained information on BRAF and NRAS mutation status by immunohistochemistry (anti-BRAF V600E, clone: VE1; Ventana ; anti-RAS Q61R, clone: SP174 Abcam , respectively) and/or next-generation sequencing (NGS) for atypical and malignant lesions. ..
Fluorescence In Situ Hybridization:Article Title: Histological interpretation of spitzoid tumours: an extensive machine learning-based concordance analysis for improving decision making.
Article Snippet: .. CDKN2A status was assessed by fluorescence in-situ hybridisation (FISH) using a 9p21 probe (Vysis LSI 9p21; Abbot Molecular Inc., Des Plaines, IL, USA), labelled with spectrum-red 2824 fluorophore, and a Chr9 centromeric probe (Vysis LSI CEP; Abbott) labelled with spectrum-green fluorophore and with Salsa methylation-specific multiplex ligationdependent probe amplification (MLPA) probemix ME024-B2 9p21 CDKN2A/2B region (MRC-Holland, Amsterdam, the Netherlands).15 We further obtained information on BRAF and NRAS mutation status by immunohistochemistry (anti-BRAF V600E, clone: VE1; Ventana ; anti-RAS Q61R, clone: SP174 Abcam , respectively) and/or next-generation sequencing (NGS) for atypical and malignant lesions. ..
Methylation:Article Title: Histological interpretation of spitzoid tumours: an extensive machine learning-based concordance analysis for improving decision making.
Article Snippet: .. CDKN2A status was assessed by fluorescence in-situ hybridisation (FISH) using a 9p21 probe (Vysis LSI 9p21; Abbot Molecular Inc., Des Plaines, IL, USA), labelled with spectrum-red 2824 fluorophore, and a Chr9 centromeric probe (Vysis LSI CEP; Abbott) labelled with spectrum-green fluorophore and with Salsa methylation-specific multiplex ligationdependent probe amplification (MLPA) probemix ME024-B2 9p21 CDKN2A/2B region (MRC-Holland, Amsterdam, the Netherlands).15 We further obtained information on BRAF and NRAS mutation status by immunohistochemistry (anti-BRAF V600E, clone: VE1; Ventana ; anti-RAS Q61R, clone: SP174 Abcam , respectively) and/or next-generation sequencing (NGS) for atypical and malignant lesions. ..
Multiplex Assay:Article Title: Histological interpretation of spitzoid tumours: an extensive machine learning-based concordance analysis for improving decision making.
Article Snippet: .. CDKN2A status was assessed by fluorescence in-situ hybridisation (FISH) using a 9p21 probe (Vysis LSI 9p21; Abbot Molecular Inc., Des Plaines, IL, USA), labelled with spectrum-red 2824 fluorophore, and a Chr9 centromeric probe (Vysis LSI CEP; Abbott) labelled with spectrum-green fluorophore and with Salsa methylation-specific multiplex ligationdependent probe amplification (MLPA) probemix ME024-B2 9p21 CDKN2A/2B region (MRC-Holland, Amsterdam, the Netherlands).15 We further obtained information on BRAF and NRAS mutation status by immunohistochemistry (anti-BRAF V600E, clone: VE1; Ventana ; anti-RAS Q61R, clone: SP174 Abcam , respectively) and/or next-generation sequencing (NGS) for atypical and malignant lesions. ..
Amplification:Article Title: Histological interpretation of spitzoid tumours: an extensive machine learning-based concordance analysis for improving decision making.
Article Snippet: .. CDKN2A status was assessed by fluorescence in-situ hybridisation (FISH) using a 9p21 probe (Vysis LSI 9p21; Abbot Molecular Inc., Des Plaines, IL, USA), labelled with spectrum-red 2824 fluorophore, and a Chr9 centromeric probe (Vysis LSI CEP; Abbott) labelled with spectrum-green fluorophore and with Salsa methylation-specific multiplex ligationdependent probe amplification (MLPA) probemix ME024-B2 9p21 CDKN2A/2B region (MRC-Holland, Amsterdam, the Netherlands).15 We further obtained information on BRAF and NRAS mutation status by immunohistochemistry (anti-BRAF V600E, clone: VE1; Ventana ; anti-RAS Q61R, clone: SP174 Abcam , respectively) and/or next-generation sequencing (NGS) for atypical and malignant lesions. ..
Multiplex Ligation-dependent Probe Amplification:Article Title: Histological interpretation of spitzoid tumours: an extensive machine learning-based concordance analysis for improving decision making.
Article Snippet: .. CDKN2A status was assessed by fluorescence in-situ hybridisation (FISH) using a 9p21 probe (Vysis LSI 9p21; Abbot Molecular Inc., Des Plaines, IL, USA), labelled with spectrum-red 2824 fluorophore, and a Chr9 centromeric probe (Vysis LSI CEP; Abbott) labelled with spectrum-green fluorophore and with Salsa methylation-specific multiplex ligationdependent probe amplification (MLPA) probemix ME024-B2 9p21 CDKN2A/2B region (MRC-Holland, Amsterdam, the Netherlands).15 We further obtained information on BRAF and NRAS mutation status by immunohistochemistry (anti-BRAF V600E, clone: VE1; Ventana ; anti-RAS Q61R, clone: SP174 Abcam , respectively) and/or next-generation sequencing (NGS) for atypical and malignant lesions. ..
Mutagenesis:Article Title: Histological interpretation of spitzoid tumours: an extensive machine learning-based concordance analysis for improving decision making.
Article Snippet: .. CDKN2A status was assessed by fluorescence in-situ hybridisation (FISH) using a 9p21 probe (Vysis LSI 9p21; Abbot Molecular Inc., Des Plaines, IL, USA), labelled with spectrum-red 2824 fluorophore, and a Chr9 centromeric probe (Vysis LSI CEP; Abbott) labelled with spectrum-green fluorophore and with Salsa methylation-specific multiplex ligationdependent probe amplification (MLPA) probemix ME024-B2 9p21 CDKN2A/2B region (MRC-Holland, Amsterdam, the Netherlands).15 We further obtained information on BRAF and NRAS mutation status by immunohistochemistry (anti-BRAF V600E, clone: VE1; Ventana ; anti-RAS Q61R, clone: SP174 Abcam , respectively) and/or next-generation sequencing (NGS) for atypical and malignant lesions. ..
Immunohistochemistry:Article Title: Histological interpretation of spitzoid tumours: an extensive machine learning-based concordance analysis for improving decision making.
Article Snippet: .. CDKN2A status was assessed by fluorescence in-situ hybridisation (FISH) using a 9p21 probe (Vysis LSI 9p21; Abbot Molecular Inc., Des Plaines, IL, USA), labelled with spectrum-red 2824 fluorophore, and a Chr9 centromeric probe (Vysis LSI CEP; Abbott) labelled with spectrum-green fluorophore and with Salsa methylation-specific multiplex ligationdependent probe amplification (MLPA) probemix ME024-B2 9p21 CDKN2A/2B region (MRC-Holland, Amsterdam, the Netherlands).15 We further obtained information on BRAF and NRAS mutation status by immunohistochemistry (anti-BRAF V600E, clone: VE1; Ventana ; anti-RAS Q61R, clone: SP174 Abcam , respectively) and/or next-generation sequencing (NGS) for atypical and malignant lesions. ..
Next-Generation Sequencing:Article Title: Histological interpretation of spitzoid tumours: an extensive machine learning-based concordance analysis for improving decision making.
Article Snippet: .. CDKN2A status was assessed by fluorescence in-situ hybridisation (FISH) using a 9p21 probe (Vysis LSI 9p21; Abbot Molecular Inc., Des Plaines, IL, USA), labelled with spectrum-red 2824 fluorophore, and a Chr9 centromeric probe (Vysis LSI CEP; Abbott) labelled with spectrum-green fluorophore and with Salsa methylation-specific multiplex ligationdependent probe amplification (MLPA) probemix ME024-B2 9p21 CDKN2A/2B region (MRC-Holland, Amsterdam, the Netherlands).15 We further obtained information on BRAF and NRAS mutation status by immunohistochemistry (anti-BRAF V600E, clone: VE1; Ventana ; anti-RAS Q61R, clone: SP174 Abcam , respectively) and/or next-generation sequencing (NGS) for atypical and malignant lesions. ..
other:Article Title: Detection of copy number variations in melanocytic lesions utilising array based comparative genomic hybridisation.
Article Snippet: Detection of copy number variations in melanocytic lesions utilising array based comparative genomic hybridisation NIMA MESBAH ARDAKANI, CARLA THOMAS, CLEO ROBINSON, KYM MINA, NATHAN TOBIAS HARVEY, BENHUR AMANUEL AND BENJAMIN ANDREW WOOD 1Department of Anatomical Pathology, PathWest Laboratory Medicine, Queen Elizabeth II Medical Centre, Nedlands, 2University of Western Australia, School of Pathology and Laboratory Medicine, Crawley, and 3Department of Diagnostic Genomics, PathWest Laboratory Medicine, Queen Elizabeth II Medical Centre, Nedlands, WA, Australia
|